Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lipid metabolism disorder in diabetic kidney disease
Yi-Zhen Han, Bo-Xuan Du, Xingyu Zhu, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 9

Showing 9 citing articles:

Mechanisms, Biomarkers, and Treatment Approaches for Diabetic Kidney Disease: Current Insights and Future Perspectives
Jean Paule Joumaa, Angela Raffoul, Claudia Sarkis, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 3, pp. 727-727
Open Access | Times Cited: 2
α-methyltryptophan-mediated protection against diabetic nephropathy in db/db mice as studied with a metabolomics approach
Aimin Cai, Dan Shen, Qiushuang Xiong, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access | Times Cited: 1
Exploring the interplay between adipokine-mediated celastrol target genes and T cells in diabetic nephropathy: a mendelian randomization-based causal inference
Xiaojuan Wang, Mohamad Hafizi Abu Bakar, Mohd Asyraf Kassim, et al.
Diabetology & Metabolic Syndrome (2025) Vol. 17, Iss. 1
Open Access
Discovery of the pharmacodynamic material basis of Danggui Buxue Decoction in the treatment of diabetic kidney disease based on lipidomics regulation
Xu Wang, Jing Liu, Tingting Liu, et al.
Phytomedicine (2025), pp. 156643-156643
Closed Access
The Non-High-Density Lipoprotein Cholesterol (Non-HDL-C) to HDL-C Ratio (NHHR) and Its Association with Chronic Kidney Disease in Chinese Adults with Type 2 Diabetes: A Preliminary Study
Xiangyu Chen, Mingbin Liang, Jie Zhang, et al.
Nutrients (2025) Vol. 17, Iss. 7, pp. 1125-1125
Open Access
Emerging Biomarkers and Innovative Therapeutic Strategies in Diabetic Kidney Disease: A Pathway to Precision Medicine
Sahana Shetty, Renuka Suvarna, Avivar Awasthi, et al.
Diagnostics (2025) Vol. 15, Iss. 8, pp. 973-973
Open Access
Exercise as a therapeutic approach to alleviate diabetic kidney disease: mechanisms, clinical evidence and potential exercise prescriptions
Rao Fan, Jianda Kong, Jiahao Zhang, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 2
Analysis of the microecological mechanism of diabetic kidney disease based on the theory of “gut–kidney axis”: A systematic review
Lili Huang, Wenjing Wu, Xiaoqin Wang
Open Life Sciences (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
CD3D silencing alleviates diabetic nephropathy via inhibition of JAK/STAT pathway
Xianghong Lei, Fangqin Zou, Xianhu Tang, et al.
The FASEB Journal (2024) Vol. 38, Iss. 21
Closed Access
Integrating lipidomics, 16S rRNA sequencing, and network pharmacology to explore the mechanism of Qikui granule in treating diabetic kidney disease mice
Qing You, Lin Yang, Jia‐Hui Gong, et al.
Journal of Chromatography B (2024) Vol. 1250, pp. 124378-124378
Closed Access
Page 1

Scroll to top